Drug detox for Lake Worth Beach — substance-specific protocols, not one-size-fits-all.
A specialist outpatient program for clients in Lake Worth Beach. PHP, IOP, in-house psychiatry, sober-living network, family programming. Same admissions team, 24/7.
Start the conversation Or call directly — (561) 464-4077Local options exist. This is the clinical specialist.
RECO Island runs drug detox 14 miles south of Lake Worth Beach on a small-census, physician-led unit — COWS/CIWA-driven, with MAT initiated during detox and continued through residential and PHP/IOP on the same campus. No waitlist, no third-party detox subcontractor, no interval between medical stabilization and clinical work. The same medical team follows the case from admission through residential discharge, and Lake Worth Beach families reach the campus in about 22 minutes for weekly in-person family therapy during the residential phase.
Lake Worth Beach sits 14 miles up the coast from RECO Island’s Delray Beach campus — a 22-minute drive down A1A that lengthens in season but rarely blocks admission. Residents of Bryant Park, College Park, Mango Groves, Parrot Cove, and the downtown corridor who enter drug detox at RECO Island stay close enough that family visits, discharge planning into local outpatient care, and continuity through PHP and IOP remain practical rather than logistical. What follows describes how detox is actually run — substance-specific protocols, medically supervised on a small census, and structured to hand off directly into residential treatment rather than to close after a week with no plan.
Substance-specific withdrawal protocols
Opioid, benzodiazepine, and stimulant withdrawal are clinically distinct syndromes that respond to different management. Running a single protocol across all substances is bad medicine and produces the outcomes it deserves. RECO Island’s admitting physician stratifies withdrawal management by substance class from the first hour on the unit, using the Clinical Opiate Withdrawal Scale (COWS) for opioids and the Clinical Institute Withdrawal Assessment (CIWA-Ar) for alcohol and sedative-hypnotics.
Opioid withdrawal is intensely uncomfortable but rarely medically dangerous in an otherwise healthy adult. The clinical decision is medication choice, not whether to medicate. Buprenorphine induction timed to a COWS score in the moderate range — to avoid precipitated withdrawal — transforms the subjective experience within 60 to 90 minutes and stabilizes cravings for the residential phase. In select cases (pregnancy, prior buprenorphine failure, high-dose fentanyl exposure), methadone or extended low-dose buprenorphine protocols are considered.
Benzodiazepine withdrawal is a different problem. Untreated, it produces autonomic instability and, in severe presentations, seizures. RECO Island converts short half-life benzodiazepines (alprazolam, lorazepam) to a long half-life agent — typically clonazepam or diazepam — and tapers over weeks. Stimulant withdrawal from cocaine or methamphetamine produces profound depression, anhedonia, hypersomnia, and craving without a specific pharmacotherapy, but still requires clinical attention: suicidality screening with the PHQ-9 and Columbia Protocol, sleep support, nutritional rehabilitation, and short-course symptomatic medications such as quetiapine or mirtazapine when clinically indicated.
Polysubstance detox and the sequencing decision
Concurrent use of alcohol, benzodiazepines, and opioids has become the modal presentation rather than the exception. Sequencing these withdrawals correctly is what separates a competent detox from a dangerous one. The operating principle is straightforward: manage life-threatening withdrawal syndromes first, initiate opioid maintenance concurrently, and address stimulant withdrawal supportively.
In practical terms, alcohol and benzodiazepine withdrawal are actively taper-managed on a CIWA-driven protocol from admission, buprenorphine is induced once the opioid withdrawal window opens (usually 12 to 24 hours after last short-acting opioid use, longer for methadone), and stimulant withdrawal is supported with sleep-architecture repair, PHQ-9 monitoring, and hydration rather than deferred. Every polysubstance plan is individualized to the specific substances used, in what quantities, over what duration, and it is documented in writing before the first dose is administered.
Medical comorbidity is the norm, not the exception
Chronic substance use produces medical comorbidity that has usually gone unaddressed for years. Injection opioid use carries hepatitis C prevalence high enough that universal screening is standard on the RECO Island admission panel. Stimulant use produces cardiovascular pathology — hypertension, cardiomyopathy, coronary vasospasm — that often shows up on the admission EKG and BMP for the first time. Alcohol use disorder produces liver disease, thiamine deficiency, and a specific cluster of nutritional deficits that require parenteral repletion during the first days on the unit.
The remainder of the medical picture is less dramatic but no less important: uncontrolled diabetes, untreated hypertension, obstructive sleep apnea diagnosed only after someone else observes the apneic episodes on the unit, chronic pain that was under-treated by primary care and then self-medicated with opioids or alcohol. The admission workup — history and physical, CBC, CMP, hepatitis panel, EKG, urine toxicology, pregnancy testing where indicated — is designed to catch these conditions and manage them during the residential phase rather than deferring the entire medical problem to an outpatient primary care visit that often does not happen.
The handoff into residential and MAT continuation
Detox produces safe withdrawal. Residential produces the early-recovery skill building — CBT for relapse prevention, DBT skills for affect regulation, MI to sustain change talk, and trauma-focused work (EMDR, cognitive processing therapy) when the trauma history warrants it — that a five- to seven-day detox cannot deliver. Medication-assisted treatment protects against relapse during the vulnerable months that follow discharge.
RECO Island’s model is to initiate MAT during detox where clinically indicated, continue it through residential and PHP/IOP without interruption, and hand off to community MAT prescribers at discharge. Buprenorphine is continued for opioid use disorder. Naltrexone — oral or extended-release injectable — is used for alcohol use disorder and for OUD after an appropriate opioid-free window (typically 7 to 10 days for oral naltrexone induction). Detox alone, without residential and without MAT continuation, produces a relapse rate documented in the literature at figures approaching universality. The point of running detox on the same campus as residential is to eliminate the interval where that relapse tends to occur.
What admission from Lake Worth Beach looks like
Admissions is a phone call. A licensed clinician conducts a telephone assessment structured around the ASAM Criteria — the six dimensions covering acute intoxication and withdrawal potential, biomedical conditions, emotional and cognitive conditions, readiness to change, relapse potential, and recovery environment — and determines the appropriate level of care. Most Lake Worth Beach residents entering drug detox are placed at ASAM 4.0 (medically managed inpatient withdrawal management) or 3.7 (medically monitored) based on withdrawal risk and medical acuity.
Insurance is verified during the same call. Transport from Lake Worth Beach is arranged when needed; most clients are admitted the same day the call is placed. Physical arrival at the Delray Beach campus is followed by a medical H&P within hours, a psychiatric evaluation within 24 hours, and the withdrawal management protocol running from the moment scoring begins to indicate initiation.
Insurance and admissions from Lake Worth Beach
RECO Island is in-network with the major commercial carriers Lake Worth Beach residents typically hold — Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans. Verification of benefits is completed before admission, and out-of-pocket exposure (deductible remaining, coinsurance percentage, out-of-pocket maximum) is disclosed in writing before any commitment is asked of the family. Detox is almost always a covered benefit under the substance use disorder provisions of the ACA; the residential and PHP/IOP levels that follow are covered under the same policy in nearly all cases, with concurrent utilization review handled by RECO Island’s clinical team rather than pushed onto the family.
Serving residents of: Bryant Park, College Park, Mango Groves, Parrot Cove, downtown Lake Worth.
If it's any of these, we can help.
From Lake Worth Beach callers, most asked.
Does insurance cover drug detox at RECO Island for Lake Worth Beach residents?
How long does drug detox take?
What happens on the first day of admission?
Is medical detox necessary for opioid withdrawal, or can someone just tough it out?
How do I get to RECO Island from Lake Worth Beach?
How is the family involved during detox and residential?
Other lake worth beach-area communities we serve.
Confidential. No commitment.
Tell us a little and a real human from admissions will call you back. We verify insurance benefits within minutes and tell you honestly whether RECO Island is the right fit — including if we should refer you elsewhere.


